Patents by Inventor Mark Messenbaugh

Mark Messenbaugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer Biomarkers and Uses Thereof
    Publication number: 20120165217
    Abstract: The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of cancer. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to diagnose cancer. In another aspect, methods are provided for diagnosing cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 24, wherein the individual is classified as having cancer, or the likelihood of the individual having cancer is determined, based on the at least one biomarker value.
    Type: Application
    Filed: April 3, 2010
    Publication date: June 28, 2012
    Applicant: SOMALOGIC, INC.
    Inventors: Larry Gold, Edward N. Brody, Rachel M. Ostroff, Dominic Zichi, Alex A.E. Stewart, Michael Riel-Mehan, Mark Messenbaugh, Randee S. Schwartz, Jeffery Walker, Stephen Alaric Williams, Malti Nikrad
  • Cancer Biomarkers and Uses Thereof
    Publication number: 20120143805
    Abstract: The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of cancer. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to diagnose cancer. In another aspect, methods are provided for diagnosing cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 47, wherein the individual is classified as having cancer, or the likelihood of the individual having cancer is determined, based on the at least one biomarker value.
    Type: Application
    Filed: March 5, 2010
    Publication date: June 7, 2012
    Applicant: SOMALOGIC, INC.
    Inventors: Larry Gold, Edward N. Brody, Rachel M. Ostroff, Dominic Zichi, Alex A.E. Stewart, Michael Riel-Mehan, Mark Messenbaugh, Randee S. Schwartz, Jeffery Walker, Stephen Alaric Williams, Malti Nikrad